Highlights from CUA 2017

REVIEW UroToday

Viewing 1-20 of 45 articles

CUA 2017: What’s New in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer?

CUA 2017: Four vs. 10 Months of Induction Androgen-Deprivation Therapy for Intermittent Therapy (the FIT trial): A Prospective Canadian Urology Research Consortium Randomized Trial

CUA 2017: A Propensity Score Analysis of Radical Cystectomy vs. Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic

CUA 2017: Safety of Minimizing Intensity of Followup on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors

CUA 2017: Long-Term Incidence of Venous Thromboembolic Events Following cystectomy: A Population-Based Analysis

CUA 2017: Radical Cystectomy After Prior Partial Cystectomy for Urothelial Carcinoma: Perioperative and Oncological Outcomes

CUA 2017: Creation of a Prediction Tool for Renal Function After Partial and Radical Nephrectomy: Personalizing Decision-Making for Renal Cancer Surgery

CUA 2017: Correlation of Transperineal Prostate Biopsy-Detected Cancer with Magnetic Resonance Imaging-Predicted Lesion in Patients with Previous Negative Transrectal Ultrasound-Guided Prostate Biopsies

CUA 2017: Is Tumor Location in Upper Tract Urothelial Carcinoma an Important Prognostic Factor?

CUA 2017: Cystic Renal Masses: Is the Bosniak Classification System an Adequate Predictor of Survival?

CUA 2017: The Prevalence and Biopsychosocial Predictors of Suicidality in Men with Prostate Cancer

CUA 2017: Population-Based Analysis of Treatment Toxicity Among Men with Castration-Resistant Prostate Cancer (mCRPC)

CUA 2017: Perioperative Chemotherapy does not Improve Disease-Free Survival in Upper Tract Urothelial Carcinoma: A Population-Based Analysis

CUA 2017: Changes in the Outcome of Prostate Biopsies after Preventive Task Force Recommendation Against PSA Screening

CUA 2017: Fatigue in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Enzalutamide: Data from Randomized Clinical Trials

CUA 2017: Medication Use and Kidney Cancer Risk: A Population-Based Study

CUA 2017: The Role of Delayed Orchiectomy Following Chemotherapy in Metastatic Germ Cell Tumors, The Princess Margaret Cancer Centre Experience

CUA 2017: Phase II Trial of Atezolizumab in Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer

CUA 2017: A Cost-Effectiveness Analysis of Hexaminolevulinate Blue Light-Assisted Transurethral Resection of Bladder Tumors in a Universal Healthcare System

CUA 2017: Impact of Abiraterone Acetate in Post-Docetaxel Setting on the Survival of Metastatic Castration-Resistant Prostate Cancer Patients: A Population-Based Study in Quebec

1
2
3